PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Virology, Wageningen University, Wageningen, The Netherlands.\', \'Bioprocess Engineering, Wageningen University, Wageningen, The Netherlands.\', \'AdaptVac Aps, Hørsholm, Denmark.\', \'Laboratory of Biochemistry, Wageningen University, Wageningen, the Netherlands.\', \'Laboratory of Phytopathology, Wageningen University, Wageningen, The Netherlands.\', \'QIMR Berghofer Medical Research Institutegrid.1049.c, Brisbane, Australia.\', \'Department of Medical Microbiology, Leiden University Medical Centergrid.10419.3d, Leiden, Netherlands.\', \'Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.\', \'ExpreS2ion Biotechnologies Aps, Hørsholm, Denmark.\', \'Applikon Biotechnology BV, Delft, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/mBio.01813-21
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 34634927
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34634927>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34634927>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all